APO Research
Talk to an analyst

APO RESEARCH · REPORT

Recombinant Bone Morphogenetic Protein-2

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Recombinant Bone Morphogenetic Protein-2 Market Outlook and Growth Opportunities 2026

29 December 2025198 pages

Choose your research edition.

Industry ResearchRecombinant Bone Morphogenetic Protein-2 Industry Research Report 2026109 pages · $2,950 USDIndustry Growth & TrendsGlobal Recombinant Bone Morphogenetic Protein-2 Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Recombinant Bone Morphogenetic Protein-2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Recombinant Bone Morphogenetic Protein-2 Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Recombinant Bone Morphogenetic Protein-2 Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Recombinant Bone Morphogenetic Protein-2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Recombinant Bone Morphogenetic Protein-2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Recombinant Bone Morphogenetic Protein-2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Recombinant Bone Morphogenetic Protein-2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Recombinant Bone Morphogenetic Protein-2 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Recombinant Bone Morphogenetic Protein-2 market include Cellumed, Jiuyuan Gene Engineering and Medtronic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Recombinant Bone Morphogenetic Protein-2 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Recombinant Bone Morphogenetic Protein-2 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Recombinant Bone Morphogenetic Protein-2 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Recombinant Bone Morphogenetic Protein-2 market size, projected growth trends, production technologies, key applications, and end-use industries.

Recombinant Bone Morphogenetic Protein-2 Segment by Company

Cellumed

Jiuyuan Gene Engineering

Medtronic

Recombinant Bone Morphogenetic Protein-2 Segment by Type

Sponge Carrier

Hydroxyapatite Carrier

Recombinant Bone Morphogenetic Protein-2 Segment by Application

Reconstructive

Oral Maxillofacial Surgery

Spinal Fusion

Trauma Surgery

Recombinant Bone Morphogenetic Protein-2 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Recombinant Bone Morphogenetic Protein-2 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Recombinant Bone Morphogenetic Protein-2 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Recombinant Bone Morphogenetic Protein-2 significant trends, drivers, influence factors in global and regions.

6. To analyze Recombinant Bone Morphogenetic Protein-2 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Recombinant Bone Morphogenetic Protein-2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Recombinant Bone Morphogenetic Protein-2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Recombinant Bone Morphogenetic Protein-2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Recombinant Bone Morphogenetic Protein-2 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Recombinant Bone Morphogenetic Protein-2 industry.

Chapter 3: Detailed analysis of Recombinant Bone Morphogenetic Protein-2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Recombinant Bone Morphogenetic Protein-2 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Recombinant Bone Morphogenetic Protein-2 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Recombinant Bone Morphogenetic Protein-2 Industry Trends Table 2. Recombinant Bone Morphogenetic Protein-2 Industry Drivers Table 3. Recombinant Bone Morphogenetic Protein-2 Industry Opportunities and Challenges Table 4. Recombinant Bone Morphogenetic Protein-2 Industry Restraints Table 5. Global Recombinant Bone Morphogenetic Protein-2 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Recombinant Bone Morphogenetic Protein-2 Revenue Share by Company (2021-2026) Table 7. Global Recombinant Bone Morphogenetic Protein-2 Sales Volume by Company (Units) & (2021-2026) Table 8. Global Recombinant Bone Morphogenetic Protein-2 Sales Volume Share by Company (2021-2026) Table 9. Global Recombinant Bone Morphogenetic Protein-2 Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Recombinant Bone Morphogenetic Protein-2 Company Ranking, (2024-2026) & (USD Million) Table 11. Global Recombinant Bone Morphogenetic Protein-2 Key Company Manufacturing Base & Headquarters Table 12. Global Recombinant Bone Morphogenetic Protein-2 Company, Product Type & Application Table 13. Global Recombinant Bone Morphogenetic Protein-2 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Recombinant Bone Morphogenetic Protein-2 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Sponge Carrier Table 18. Significant Companies of Hydroxyapatite Carrier Table 19. Global Recombinant Bone Morphogenetic Protein-2 Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 20. Global Recombinant Bone Morphogenetic Protein-2 Sales Volume by Type (2021-2026) & (Units) Table 21. Global Recombinant Bone Morphogenetic Protein-2 Sales Volume by Type (2027-2032) & (Units) Table 22. Global Recombinant Bone Morphogenetic Protein-2 Sales Volume Share by Type (2021-2026) Table 23. Global Recombinant Bone Morphogenetic Protein-2 Sales Volume Share by Type (2027-2032) Table 24. Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type (2021-2026) Table 28. Global Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Reconstructive Table 30. Significant Companies of Oral Maxillofacial Surgery Table 31. Significant Companies of Spinal Fusion Table 32. Significant Companies of Trauma Surgery Table 33. Global Recombinant Bone Morphogenetic Protein-2 Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 34. Global Recombinant Bone Morphogenetic Protein-2 Sales Volume by Application (2021-2026) & (Units) Table 35. Global Recombinant Bone Morphogenetic Protein-2 Sales Volume by Application (2027-2032) & (Units) Table 36. Global Recombinant Bone Morphogenetic Protein-2 Sales Volume Share by Application (2021-2026) Table 37. Global Recombinant Bone Morphogenetic Protein-2 Sales Volume Share by Application (2027-2032) Table 38. Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application (2021-2026) Table 42. Global Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application (2027-2032) Table 43. Global Recombinant Bone Morphogenetic Protein-2 Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 44. Global Recombinant Bone Morphogenetic Protein-2 Sales by Region (2021-2026) & (Units) Table 45. Global Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Region (2021-2026) Table 46. Global Recombinant Bone Morphogenetic Protein-2 Sales by Region (2027-2032) & (Units) Table 47. Global Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Region (2027-2032) Table 48. Global Recombinant Bone Morphogenetic Protein-2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Region (2021-2026) Table 51. Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Region (2027-2032) Table 53. Global Recombinant Bone Morphogenetic Protein-2 Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Recombinant Bone Morphogenetic Protein-2 Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Recombinant Bone Morphogenetic Protein-2 Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 56. Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Recombinant Bone Morphogenetic Protein-2 Sales by Country (2021-2026) & (Units) Table 58. Global Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Country (2021-2026) Table 59. Global Recombinant Bone Morphogenetic Protein-2 Sales by Country (2027-2032) & (Units) Table 60. Global Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Country (2027-2032) Table 61. Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Recombinant Bone Morphogenetic Protein-2 Sales Value Market Share by Country (2021-2026) Table 63. Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Recombinant Bone Morphogenetic Protein-2 Sales Value Market Share by Country (2027-2032) Table 65. Cellumed Company Information Table 66. Cellumed Business Overview Table 67. Cellumed Recombinant Bone Morphogenetic Protein-2 Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Cellumed Recombinant Bone Morphogenetic Protein-2 Product Portfolio Table 69. Cellumed Recent Development Table 70. Jiuyuan Gene Engineering Company Information Table 71. Jiuyuan Gene Engineering Business Overview Table 72. Jiuyuan Gene Engineering Recombinant Bone Morphogenetic Protein-2 Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Jiuyuan Gene Engineering Recombinant Bone Morphogenetic Protein-2 Product Portfolio Table 74. Jiuyuan Gene Engineering Recent Development Table 75. Medtronic Company Information Table 76. Medtronic Business Overview Table 77. Medtronic Recombinant Bone Morphogenetic Protein-2 Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Medtronic Recombinant Bone Morphogenetic Protein-2 Product Portfolio Table 79. Medtronic Recent Development Table 80. Key Raw Materials Table 81. Raw Materials Key Suppliers Table 82. Recombinant Bone Morphogenetic Protein-2 Distributors List Table 83. Recombinant Bone Morphogenetic Protein-2 Customers List Table 84. Research Programs/Design for This Report Table 85. Authors List of This Report Table 86. Secondary Sources Table 87. Primary Sources List of Figures Figure 1. Recombinant Bone Morphogenetic Protein-2 Product Image Figure 2. Global Recombinant Bone Morphogenetic Protein-2 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Recombinant Bone Morphogenetic Protein-2 Sales Value (2021-2032) & (US$ Million) Figure 4. Global Recombinant Bone Morphogenetic Protein-2 Sales (2021-2032) & (Units) Figure 5. Global Recombinant Bone Morphogenetic Protein-2 Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Recombinant Bone Morphogenetic Protein-2 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Sponge Carrier Image Figure 10. Hydroxyapatite Carrier Image Figure 11. Global Recombinant Bone Morphogenetic Protein-2 Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 12. Global Recombinant Bone Morphogenetic Protein-2 Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Recombinant Bone Morphogenetic Protein-2 Sales Volume Share by Type (2021-2032) Figure 14. Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Recombinant Bone Morphogenetic Protein-2 Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type (2021-2032) Figure 17. Reconstructive Image Figure 18. Oral Maxillofacial Surgery Image Figure 19. Spinal Fusion Image Figure 20. Trauma Surgery Image Figure 21. Global Recombinant Bone Morphogenetic Protein-2 Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 22. Global Recombinant Bone Morphogenetic Protein-2 Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Recombinant Bone Morphogenetic Protein-2 Sales Volume Share by Application (2021-2032) Figure 24. Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Recombinant Bone Morphogenetic Protein-2 Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application (2021-2032) Figure 27. Global Recombinant Bone Morphogenetic Protein-2 Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 28. Global Recombinant Bone Morphogenetic Protein-2 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Recombinant Bone Morphogenetic Protein-2 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Recombinant Bone Morphogenetic Protein-2 Sales Value (2021-2032) & (US$ Million) Figure 32. North America Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Recombinant Bone Morphogenetic Protein-2 Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Recombinant Bone Morphogenetic Protein-2 Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Recombinant Bone Morphogenetic Protein-2 Sales Value (2021-2032) & (US$ Million) Figure 38. South America Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Recombinant Bone Morphogenetic Protein-2 Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Recombinant Bone Morphogenetic Protein-2 Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Recombinant Bone Morphogenetic Protein-2 Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Sponge Carrier
  • Hydroxyapatite Carrier
Applications
  • Reconstructive
  • Oral Maxillofacial Surgery
  • Spinal Fusion
  • Trauma Surgery
Companies covered
  • Cellumed
  • Jiuyuan Gene Engineering
  • Medtronic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Recombinant Bone Morphogenetic Protein-2 Sales Value (2021-2032)
  4. 1.2.2 Global Recombinant Bone Morphogenetic Protein-2 Sales Volume (2021-2032)
  5. 1.2.3 Global Recombinant Bone Morphogenetic Protein-2 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Recombinant Bone Morphogenetic Protein-2 Market Dynamics
  1. 2.1 Recombinant Bone Morphogenetic Protein-2 Industry Trends
  2. 2.2 Recombinant Bone Morphogenetic Protein-2 Industry Drivers
  3. 2.3 Recombinant Bone Morphogenetic Protein-2 Industry Opportunities and Challenges
  4. 2.4 Recombinant Bone Morphogenetic Protein-2 Industry Restraints
3 Recombinant Bone Morphogenetic Protein-2 Market by Company
  1. 3.1 Global Recombinant Bone Morphogenetic Protein-2 Company Revenue Ranking in 2025
  2. 3.2 Global Recombinant Bone Morphogenetic Protein-2 Revenue by Company (2021-2026)
  3. 3.3 Global Recombinant Bone Morphogenetic Protein-2 Sales Volume by Company (2021-2026)
  4. 3.4 Global Recombinant Bone Morphogenetic Protein-2 Average Price by Company (2021-2026)
  5. 3.5 Global Recombinant Bone Morphogenetic Protein-2 Company Ranking (2024-2026)
  6. 3.6 Global Recombinant Bone Morphogenetic Protein-2 Company Manufacturing Base and Headquarters
  7. 3.7 Global Recombinant Bone Morphogenetic Protein-2 Company Product Type and Application
  8. 3.8 Global Recombinant Bone Morphogenetic Protein-2 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Recombinant Bone Morphogenetic Protein-2 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Recombinant Bone Morphogenetic Protein-2 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Recombinant Bone Morphogenetic Protein-2 Market by Type
  1. 4.1 Recombinant Bone Morphogenetic Protein-2 Type Introduction
  2. 4.1.1 Sponge Carrier
  3. 4.1.2 Hydroxyapatite Carrier
  4. 4.2 Global Recombinant Bone Morphogenetic Protein-2 Sales Volume by Type
  5. 4.2.1 Global Recombinant Bone Morphogenetic Protein-2 Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Recombinant Bone Morphogenetic Protein-2 Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Recombinant Bone Morphogenetic Protein-2 Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Type
  9. 4.3.1 Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Type (2021-2032)
  11. 4.3.3 Global Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type (2021-2032)
5 Recombinant Bone Morphogenetic Protein-2 Market by Application
  1. 5.1 Recombinant Bone Morphogenetic Protein-2 Application Introduction
  2. 5.1.1 Reconstructive
  3. 5.1.2 Oral Maxillofacial Surgery
  4. 5.1.3 Spinal Fusion
  5. 5.1.4 Trauma Surgery
  6. 5.2 Global Recombinant Bone Morphogenetic Protein-2 Sales Volume by Application
  7. 5.2.1 Global Recombinant Bone Morphogenetic Protein-2 Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Recombinant Bone Morphogenetic Protein-2 Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Recombinant Bone Morphogenetic Protein-2 Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Application
  11. 5.3.1 Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Application (2021-2032)
  13. 5.3.3 Global Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application (2021-2032)
6 Recombinant Bone Morphogenetic Protein-2 Regional Sales and Value Analysis
  1. 6.1 Global Recombinant Bone Morphogenetic Protein-2 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Recombinant Bone Morphogenetic Protein-2 Sales by Region (2021-2032)
  3. 6.2.1 Global Recombinant Bone Morphogenetic Protein-2 Sales by Region: 2021-2026
  4. 6.2.2 Global Recombinant Bone Morphogenetic Protein-2 Sales by Region (2027-2032)
  5. 6.3 Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Region (2021-2032)
  7. 6.4.1 Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Region: 2021-2026
  8. 6.4.2 Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Region (2027-2032)
  9. 6.5 Global Recombinant Bone Morphogenetic Protein-2 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Recombinant Bone Morphogenetic Protein-2 Sales Value (2021-2032)
  12. 6.6.2 North America Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Recombinant Bone Morphogenetic Protein-2 Sales Value (2021-2032)
  15. 6.7.2 Europe Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Recombinant Bone Morphogenetic Protein-2 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Recombinant Bone Morphogenetic Protein-2 Sales Value (2021-2032)
  21. 6.9.2 South America Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Recombinant Bone Morphogenetic Protein-2 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Country, 2025 VS 2032
7 Recombinant Bone Morphogenetic Protein-2 Country-level Sales and Value Analysis
  1. 7.1 Global Recombinant Bone Morphogenetic Protein-2 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Recombinant Bone Morphogenetic Protein-2 Sales by Country (2021-2032)
  4. 7.3.1 Global Recombinant Bone Morphogenetic Protein-2 Sales by Country (2021-2026)
  5. 7.3.2 Global Recombinant Bone Morphogenetic Protein-2 Sales by Country (2027-2032)
  6. 7.4 Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Country (2021-2032)
  7. 7.4.1 Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Country (2021-2026)
  8. 7.4.2 Global Recombinant Bone Morphogenetic Protein-2 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Recombinant Bone Morphogenetic Protein-2 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Recombinant Bone Morphogenetic Protein-2 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Cellumed
  2. 8.1.1 Cellumed Company Information
  3. 8.1.2 Cellumed Business Overview
  4. 8.1.3 Cellumed Recombinant Bone Morphogenetic Protein-2 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Cellumed Recombinant Bone Morphogenetic Protein-2 Product Portfolio
  6. 8.1.5 Cellumed Recent Developments
  7. 8.2 Jiuyuan Gene Engineering
  8. 8.2.1 Jiuyuan Gene Engineering Company Information
  9. 8.2.2 Jiuyuan Gene Engineering Business Overview
  10. 8.2.3 Jiuyuan Gene Engineering Recombinant Bone Morphogenetic Protein-2 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Jiuyuan Gene Engineering Recombinant Bone Morphogenetic Protein-2 Product Portfolio
  12. 8.2.5 Jiuyuan Gene Engineering Recent Developments
  13. 8.3 Medtronic
  14. 8.3.1 Medtronic Company Information
  15. 8.3.2 Medtronic Business Overview
  16. 8.3.3 Medtronic Recombinant Bone Morphogenetic Protein-2 Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Medtronic Recombinant Bone Morphogenetic Protein-2 Product Portfolio
  18. 8.3.5 Medtronic Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Recombinant Bone Morphogenetic Protein-2 Value Chain Analysis
  2. 9.1.1 Recombinant Bone Morphogenetic Protein-2 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Recombinant Bone Morphogenetic Protein-2 Sales Mode & Process
  6. 9.2 Recombinant Bone Morphogenetic Protein-2 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Recombinant Bone Morphogenetic Protein-2 Distributors
  9. 9.2.3 Recombinant Bone Morphogenetic Protein-2 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst